SA
ABBV icon

Sonoma Allocations’s AbbVie ABBV Stock Holding History

Sonoma Allocations’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$404K Sell
1,614
-462
-22% -$99.4K 0.13% 89
2026
Q1 		$427K Sell
2,076
-596
-22% -$132K 0.15% 103
2025
Q4 		$602K Buy
2,672
+793
+42% +$181K 0.2% 67
2025
Q3 		$424K Buy
+1,879
New +$383K 0.15% 81

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sonoma Allocations's ABBV Position: Q2 2026 in Review

Sonoma Allocations reduced its AbbVie (ABBV) stake by 22% in Q2 2026, selling an estimated $99.4K and leaving 1,614 shares worth $404K. The position accounts for 0.13% of the portfolio, ranked #89.

Sonoma Allocations first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. The position peaked at $602K in Q4 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sonoma Allocations held 1,614 shares of AbbVie worth $404K as of Q2 2026.
  • Sonoma Allocations sold 462 AbbVie shares in Q2 2026, an estimated $99.4K.
  • AbbVie made up 0.13% of Sonoma Allocations's portfolio in Q2 2026, its #89 holding.
  • Sonoma Allocations first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • Sonoma Allocations's AbbVie position peaked at $602K in Q4 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sonoma Allocations's 13F filing for Q2 2026, filed 8 Jul 2026.